Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Inflammation, atrophy, and gastric cancer
James G. Fox, Timothy C. Wang
James G. Fox, Timothy C. Wang
Published January 2, 2007
Citation Information: J Clin Invest. 2007;117(1):60-69. https://doi.org/10.1172/JCI30111.
View: Text | PDF
Review Series

Inflammation, atrophy, and gastric cancer

  • Text
  • PDF
Abstract

The association between chronic inflammation and cancer is now well established. This association has recently received renewed interest with the recognition that microbial pathogens can be responsible for the chronic inflammation observed in many cancers, particularly those originating in the gastrointestinal system. A prime example is Helicobacter pylori, which infects 50% of the world’s population and is now known to be responsible for inducing chronic gastric inflammation that progresses to atrophy, metaplasia, dysplasia, and gastric cancer. This Review provides an overview of recent progress in elucidating the bacterial properties responsible for colonization of the stomach, persistence in the stomach, and triggering of inflammation, as well as the host factors that have a role in determining whether gastritis progresses to gastric cancer. We also discuss how the increased understanding of the relationship between inflammation and gastric cancer still leaves many questions unanswered regarding recommendations for prevention and treatment.

Authors

James G. Fox, Timothy C. Wang

×

Figure 4

Histological progression of Helicobacter-induced gastric cancer in a mouse model.

Options: View larger image (or click on image) Download as PowerPoint
Histological progression of Helicobacter-induced gastric cancer in a mou...
Normal: Histology of the body of the stomach. Acute gastritis: Infiltration of mucosal and submucosal lymphocytes with pockets of polymorphonuclear cells, accompanied by mild mucosal defects and edema. Chronic gastritis: Moderate to severe inflammation with marked epithelial defects including gland dilatation and mineralization. Atrophic gastritis: Chronic inflammation with focal fibrosis and complete loss of oxyntic parietal and chief cells. Intestinal metaplasia: Gastric epithelial metaplasia to an intestinal phenotype characterized by columnar elongation, mucous droplets occasionally forming goblet cells, and production of mixed acidic (blue, intestinal-type) and neutral (red, gastric-type) mucins as shown by pH 2.5 Alcian blue/PAS stain (inset). Dysplasia: High-grade glandular dysplasia characterized by irregular size and shape, infolding, branching and cell piling, and marked cellular and nuclear atypia. Cancer: Gastric intraepithelial neoplasia, here with intramucosal invasion (arrow), develops in H. pylori–infected wild-type B6129 mice, as well as in certain genetically engineered models (124–126). Scale bars: 160 μm (first panel); 400 μm (second through fourth panels); 80 μm (fifth panel; inset, original magnification, ×400); 40 μm (sixth panel); 800 μm (seventh panel). Second panel (acute gastritis): adapted with permission from American Journal of Physiology-Gastrointestinal and Liver Physiology (124). All other panels: adapted from Cancer Research (125, 126).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts